Denosumab

Welcome to Dwaey, specifically on Denosumab page.
This medicine contains important and useful components, as it consists of
Denosumab is available in the market in concentration.

Generic Name of Denosumab - Learn More

Denosumab

Denosumab Precaution - What You Need to Know

Before initiating treatment with Denosumab, it is crucial that patients consult their healthcare provider due to several important precautions:

- Hypocalcemia: Denosumab can cause low calcium levels (hypocalcemia). Patients should have their serum calcium levels checked before starting treatment and periodically during therapy, especially those with a history of calcium deficiency or vitamin D deficiency. If hypocalcemia is detected, it should be corrected before treatment begins, and calcium and vitamin D supplementation may be recommended during therapy.
- Infection Risk: Denosumab may increase the risk of infections. Patients should be monitored for symptoms of serious infections, including osteomyelitis, cellulitis, and urinary tract infections. Those with a history of chronic infections or immunocompromised conditions (e.g., HIV, cancer, or on immunosuppressive medications) should be carefully evaluated before starting therapy.
- Bone Fractures: Although Denosumab is used to strengthen bones, some patients may be at risk for atypical femur fractures. Patients on long-term therapy should be monitored for signs of bone pain or fractures, and treatment should be reconsidered in the case of persistent unexplained pain.
- Osteonecrosis of the Jaw (ONJ): Patients receiving Denosumab are at increased risk of osteonecrosis of the jaw, particularly if they are undergoing dental procedures. Dental check-ups should be conducted prior to initiating treatment, and routine oral hygiene should be maintained.
- Pregnancy and Breastfeeding: Denosumab is classified as Category X for pregnancy, meaning it can cause harm to a developing fetus. It should not be used during pregnancy or breastfeeding. Women of childbearing age should use effective contraception during treatment and for at least 5 months after stopping the medication.

Denosumab Indication - Uses and Benefits

Denosumab is primarily used for the treatment of bone-related conditions and diseases, including:

- Osteoporosis: Denosumab is prescribed to treat osteoporosis in postmenopausal women and men at high risk of fractures. It is especially beneficial in those who have a history of fractures or are unable to take oral bisphosphonates.
- Bone Loss Associated with Cancer Treatment: Denosumab is used to treat bone loss in patients with certain types of cancer, such as breast cancer or prostate cancer, who are undergoing treatments like chemotherapy or androgen deprivation therapy that may cause bone thinning.
- Giant Cell Tumor of Bone (GCTB): Denosumab is also indicated for the treatment of Giant Cell Tumor of Bone, a rare and often destructive bone tumor, in adults and skeletally mature adolescents.
- Prevention of Skeletal-Related Events in Cancer: Denosumab is used to prevent bone fractures, spinal cord compression, and other skeletal-related events in patients with bone metastases from solid tumors.

Denosumab Contraindications - Important Warnings

Denosumab is contraindicated in the following situations:

- Hypocalcemia: Denosumab should not be used in patients with pre-existing hypocalcemia. Adequate correction of low calcium levels is necessary before starting treatment.
- Pregnancy: Denosumab should not be used during pregnancy as it may harm the fetus. It is classified as Pregnancy Category X.
- Severe Renal Impairment: While it does not require dose adjustments in mild-to-moderate renal impairment, Denosumab is not recommended in patients with severe renal impairment or those requiring dialysis.
- Allergy to Denosumab or Any Components: Patients with a known hypersensitivity to Denosumab or any of its components should avoid using the medication.
- Osteonecrosis of the Jaw (ONJ): Patients with a history of osteonecrosis of the jaw should not receive Denosumab unless specifically advised by their healthcare provider.

Denosumab Side Effects - What to Expect

Denosumab, like all medications, may cause side effects. Some of the more common side effects include:

- Common Side Effects:
- Back pain
- Muscle pain
- Joint pain
- Headache
- Fatigue
- Serious Side Effects:
- Hypocalcemia: Severe low calcium levels can result in muscle spasms, cramping, or irregular heartbeats. This can be serious and require immediate medical attention.
- Infections: Increased risk of serious infections, such as urinary tract infections, cellulitis, or osteomyelitis, particularly in patients with compromised immune systems.
- Osteonecrosis of the Jaw (ONJ): Denosumab has been associated with a rare but severe condition in which the jawbone begins to die due to reduced blood flow. This is particularly concerning in patients undergoing dental procedures.
- Atypical Femur Fractures: Long-term use of Denosumab has been linked to rare cases of atypical fractures of the femur (thigh bone), typically after minimal or no trauma. Any new or unusual pain in the thigh or groin area should be evaluated.
- Skin Reactions: Some patients experience severe skin reactions, such as rashes or dermatitis.

Patients should seek medical attention if any serious side effects occur, especially if they experience signs of infection, jaw pain, unusual bone pain, or hypocalcemia symptoms.

Denosumab Pregnancy Category ID - Safety Information

5

Denosumab Mode of Action - How It Works

Denosumab is a monoclonal antibody that works by inhibiting a protein called RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand). RANKL plays a key role in the activation of osteoclasts, the cells responsible for bone resorption (breakdown). By inhibiting RANKL, Denosumab prevents the formation, function, and survival of osteoclasts, thereby reducing bone resorption and increasing bone density.

This makes Denosumab effective in treating conditions associated with bone loss, such as osteoporosis and bone metastases from cancer. The drug is typically administered via subcutaneous injection every six months for most indications, though the exact frequency may vary depending on the patient's condition and response to treatment.

Denosumab Drug Interactions - What to Avoid

Denosumab has several potential drug interactions, particularly with medications or conditions that influence calcium balance:

- Calcium Supplements and Vitamin D: Since Denosumab can lower calcium levels, it is often used alongside calcium and vitamin D supplements to prevent hypocalcemia. However, the dose of calcium and vitamin D should be carefully monitored.
- Bisphosphonates: Concurrent use with bisphosphonates (another class of bone-modifying agents) is generally not recommended. Combining these drugs may increase the risk of osteonecrosis of the jaw or other bone complications.
- Immunosuppressive Medications: Since Denosumab can increase infection risk, it should be used cautiously in patients taking immunosuppressive drugs, such as corticosteroids, chemotherapy, or biologics, as this can further increase susceptibility to infections.
- Other Bone-Related Medications: Combining Denosumab with other bone-modifying agents or therapies that affect bone metabolism should be done cautiously, and the benefits and risks should be closely monitored.

Denosumab Adult Dose - Recommended Dosage

For osteoporosis, bone loss due to cancer treatments, or bone metastases, the usual adult dose of Denosumab is:

- 60 mg administered as a subcutaneous injection once every 6 months.
- For certain conditions, such as giant cell tumor of bone, Denosumab may be administered more frequently, typically once every 4 weeks until the tumor is stabilized.

Calcium and vitamin D supplementation are usually recommended during treatment, especially for those at risk of hypocalcemia.

Denosumab Child Dose - Dosage for Children

Denosumab is not recommended for use in pediatric patients under the age of 18, as its safety and efficacy have not been established in children. It is primarily used in adults, particularly for the treatment of osteoporosis, bone metastases, and giant cell tumors. Always consult a healthcare provider for appropriate treatment options for children.

Denosumab Renal Dose - Dosage for Kidney Conditions

Denosumab does not require any dose adjustments for patients with mild-to-moderate renal impairment. However, in cases of severe renal impairment or those requiring dialysis, the use of Denosumab should be carefully evaluated by the healthcare provider, as these patients may be more susceptible to developing hypocalcemia or other complications. Routine monitoring of calcium levels is necessary for these individuals.